scout

All News

Dr. Alan Blum and Cancer Network have partnered to assemble a four-part slideshow series addressing the history of America’s smoking pandemic. Part 3 highlights a period of regulation and legislation against the tobacco industry, and litigation in the form of class action and state lawsuits.

No matter where you practice medicine, if your duties include patient care then you are going to interact with other oncologists. In some cases you may question the quality of their care. Help your peers to become better physicians by respecting them first, then relaying your concerns to them. Here are some examples of how not to do it, paired with kinder, gentler alternatives.

Do you know the prevalence of triple-negative breast cancer? How about the patient makeup in the START A and START B trials, which tested hypofractionated radiotherapy for breast cancer? Answer these questions and more.

Oncologists are excited to relay the news to patients that hard-to-treat tumors benefit from a new type of immunotherapy called checkpoint inhibition, but is there a way to explain this without putting everyone in the room to sleep?

In case you missed it, check out our March recap featuring some of the latest in clinical trial news, a new indication for Afinitor, how genetics affect prognosis, and more.

I recently spoke with someone who works for a hospital-based oncology clinic in another state. I am alarmed about the way the practice is structured. There the patient is never treated on the day they see the doctor. That means the patient must make at least two trips for every treatment. But I am told by others that this is standard.